Disclosure under Regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 25,353 equity shares (face value Rs. 10 each) through open market purchases on September 15, 2025. This represents 0.85% of the company's total share capital (29,90,300 shares). Before this acquisition, Ishita Pharmaceuticals held zero shares in the company, so the post-acquisition holding stands at 0.85%. The disclosure has been filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, with BSE Limited as the stock exchange.
This is a small stake-building move by a related party, signalling insider or related party interest in the company. At only 0.85%, the acquisition is too minor to influence stock price or change control dynamics, and is more of a compliance disclosure than a market-moving event.